BDBM274942 4-{[(3R,6R)-1-{[4- fluoro-2-(2H-1,2,3- triazol-2-yl)phenyl]- carbonyl}-6-methyl- piperidin-3- yl]oxy}furo[3,4- c]pyridin-1(3H)-one::US9556190, Example 32

SMILES C[C@@H]1CC[C@H](CN1C(=O)c1ccc(F)cc1-n1nccn1)Oc1nccc2C(=O)OCc12

InChI Key InChIKey=CSNXVVWGVAHIEP-UHFFFAOYSA-N

Data  2 IC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 2 hits for monomerid = 274942   

TargetOrexin receptor type 2(Human)
Merck Sharp & Dohme

US Patent
LigandPNGBDBM274942(4-{[(3R,6R)-1-{[4- fluoro-2-(2H-1,2,3- triazol-2-y...)
Affinity DataIC50: 15nMAssay Description: In a typical experiment the OX1 and OX2 receptor antagonistic activity of the compounds of the present invention was determined in accordance with t...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/12/2018
Entry Details
Go to US Patent

TargetOrexin/Hypocretin receptor type 1(Human)
Merck Sharp & Dohme

US Patent
LigandPNGBDBM274942(4-{[(3R,6R)-1-{[4- fluoro-2-(2H-1,2,3- triazol-2-y...)
Affinity DataIC50: 8.29E+3nMAssay Description: In a typical experiment the OX1 and OX2 receptor antagonistic activity of the compounds of the present invention was determined in accordance with t...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/12/2018
Entry Details
Go to US Patent